We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+10.47%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.2B
AUM Growth
+$114M
Cap. Flow
+$32.1M
Cap. Flow %
2.67%
Top 10 Hldgs %
22.44%
Holding
250
New
21
Increased
113
Reduced
86
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 33.62%
2 Healthcare 19.87%
3 Industrials 11.34%
4 Consumer Discretionary 8.79%
5 Financials 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVC
51
DELISTED
Invacare Corporation
IVC
$7.96M 0.66%
505,111
-308,619
-38% -$4.41M
NXST icon
52
Nexstar Media Group
NXST
$5.97B
$7.86M 0.66%
126,108
+7,145
+6% +$441K
PCTY icon
53
Paylocity
PCTY
$7.98B
$7.78M 0.65%
159,286
+11,054
+7% +$513K
QLYS icon
54
Qualys
QLYS
$6.35B
$7.77M 0.65%
150,036
+151
+0.1% +$6.93K
EXTR icon
55
Extreme Networks
EXTR
$3.15B
$7.76M 0.65%
652,929
+142,443
+28% +$1.46M
RTEC
56
DELISTED
Rudolph Technologies Inc
RTEC
$7.75M 0.65%
294,878
+12,154
+4% +$284K
EVH icon
57
Evolent Health
EVH
$447M
$7.6M 0.63%
426,764
+104,876
+33% +$2.16M
AIN icon
58
Albany International
AIN
$1.78B
$7.53M 0.63%
131,111
-92,987
-41% -$4.97M
TNC icon
59
Tennant Co
TNC
$1.26B
$7.32M 0.61%
110,624
+6,155
+6% +$412K
BIO icon
60
Bio-Rad Laboratories Class A
BIO
$9.42B
$7.19M 0.6%
32,350
-6,705
-17% -$1.51M
NTLA icon
61
Intellia Therapeutics
NTLA
$1.67B
$7.11M 0.59%
286,144
+18,784
+7% +$354K
TCBI icon
62
Texas Capital Bancshares
TCBI
$4.32B
$7.09M 0.59%
82,679
+1,668
+2% +$130K
POWI icon
63
Power Integrations
POWI
$3.61B
$7.09M 0.59%
193,746
+75,278
+64% +$2.75M
JRVR icon
64
James River Group Holdings
JRVR
$217M
$6.98M 0.58%
168,328
+32,985
+24% +$1.32M
SGMO
65
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$6.98M 0.58%
465,090
-241,769
-34% -$2.67M
IRWD icon
66
Ironwood Pharmaceuticals
IRWD
$714M
$6.88M 0.57%
520,584
+102,569
+25% +$1.41M
INST
67
DELISTED
Instructure, Inc.
INST
$6.85M 0.57%
206,741
-48,642
-19% -$1.5M
STAG icon
68
STAG Industrial
STAG
$7.19B
$6.78M 0.57%
246,895
+14,400
+6% +$398K
FRPT icon
69
Freshpet
FRPT
$3.22B
$6.65M 0.55%
425,027
+2,425
+0.6% +$39K
GIMO
70
DELISTED
Gigamon Inc.
GIMO
$6.61M 0.55%
156,724
+7,691
+5% +$314K
GWR
71
DELISTED
Genesee & Wyoming Inc.
GWR
$6.49M 0.54%
87,736
+31,105
+55% +$2.13M
EEFT icon
72
Euronet Worldwide
EEFT
$2.7B
$6.37M 0.53%
67,210
-242
-0.4% -$22.9K
PCRX icon
73
Pacira BioSciences
PCRX
$997M
$6.33M 0.53%
168,464
+27,609
+20% +$1.11M
TCMD icon
74
Tactile Systems Technology
TCMD
$665M
$6.11M 0.51%
197,537
+113,572
+135% +$3.6M
DSGR icon
75
Distribution Solutions Group
DSGR
$1.61B
$5.9M 0.49%
468,306
+39,018
+9% +$447K

Similar funds

Granahan Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Granahan Investment Management held 250 positions worth $1.2B, up 11% from $1.08B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Granahan Investment Management's Q3 2017 filing shows 21 new, 113 increased, 86 reduced and 28 closed positions. Its largest new stake was Teladoc Health: 439,501 shares worth $14.6M. The largest sale was Affiliated Managers Group, an estimated $13.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q3 2017 buy was Teladoc Health: 439,501 shares worth $14.6M.
  • Granahan Investment Management added most to Kornit Digital in Q3 2017, an estimated $13.6M increase.
  • Granahan Investment Management's biggest Q3 2017 reduction was Affiliated Managers Group, cutting an estimated $13.7M.
  • Granahan Investment Management fully exited Spectranetics Corp in Q3 2017, selling an estimated $9.39M.
  • Granahan Investment Management's ten largest holdings make up 22% of its $1.2B portfolio in Q3 2017.
  • Granahan Investment Management opened 21 new positions and closed 28 in Q3 2017.
  • Granahan Investment Management's portfolio value rose 11% quarter-over-quarter to $1.2B.

Based on Granahan Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.